Total Payments
$55,281
2024 Payments
$23,313
Companies
16
Transactions
82
Medicare Patients
12,568
Medicare Billing
$11.3M
Payment Breakdown by Category
Consulting$52,419 (94.8%)
Food & Beverage$2,862 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $52,419 | 28 | 94.8% |
| Food and Beverage | $2,862 | 54 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $48,413 | 49 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $4,548 | 5 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $1,410 | 2 | $0 (2024) |
| Dutch Ophthalmic, USA | $158.90 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $157.03 | 2 | $0 (2019) |
| Genentech USA, Inc. | $144.18 | 6 | $0 (2024) |
| Alcon Vision LLC | $112.38 | 4 | $0 (2024) |
| Genentech, Inc. | $87.50 | 1 | $0 (2022) |
| Novartis Pharma AG | $51.47 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $43.33 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,313 | 26 | Regeneron Healthcare Solutions, Inc. ($17,235) |
| 2023 | $8,228 | 15 | Regeneron Healthcare Solutions, Inc. ($8,074) |
| 2022 | $3,787 | 13 | Regeneron Healthcare Solutions, Inc. ($3,626) |
| 2021 | $3,311 | 5 | Regeneron Healthcare Solutions, Inc. ($3,262) |
| 2020 | $4,921 | 4 | Regeneron Healthcare Solutions, Inc. ($4,921) |
| 2019 | $6,405 | 7 | Regeneron Healthcare Solutions, Inc. ($6,214) |
| 2018 | $3,308 | 6 | Regeneron Healthcare Solutions, Inc. ($3,280) |
| 2017 | $2,009 | 6 | Regeneron Healthcare Solutions, Inc. ($1,801) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $3,315.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,105.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Genentech USA, Inc. | Susvimo (Drug), Vabysmo | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,657.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $77.39 | General |
| Category: Ophthalmology | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $123.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $41.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Ophthalmology | ||||||
| 08/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/08/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,105.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/09/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Ophthalmology | ||||||
| 06/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $3,867.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,105.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $552.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $3,174.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Consulting Fee | Cash or cash equivalent | $1,058.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/07/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $105.40 | General |
| Category: Ophthalmology | ||||||
| 05/06/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Consulting Fee | Cash or cash equivalent | $1,387.50 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 05/06/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 05/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $99.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/23/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Consulting Fee | Cash or cash equivalent | $4,257.00 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,358 | 26,067 | $10.0M | $3.3M |
| 2022 | 21 | 3,214 | 12,648 | $9.0M | $2.9M |
| 2021 | 17 | 3,029 | 10,432 | $7.9M | $2.6M |
| 2020 | 18 | 2,967 | 10,130 | $7.5M | $2.5M |
Total Patients
12,568
Total Services
59,277
Medicare Billing
$11.3M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 208 | 2,084 | $4.3M | $1.4M | 33.5% |
| J3490 | Unclassified drugs | Office | 2023 | 107 | 221 | $1.3M | $452,716 | 35.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 46 | 14,220 | $904,048 | $395,500 | 43.7% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 85 | 1,146 | $802,200 | $244,123 | 30.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 396 | 1,718 | $1.0M | $172,582 | 16.7% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 42 | 1,110 | $300,650 | $133,600 | 44.4% |
| 92134 | Imaging of retina | Office | 2023 | 827 | 2,717 | $301,587 | $85,116 | 28.2% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 24 | 427 | $178,500 | $65,737 | 36.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 493 | 611 | $146,640 | $58,066 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 456 | 708 | $123,900 | $45,976 | 37.1% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 11 | 256 | $153,000 | $45,082 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 394 | $98,106 | $37,722 | 38.5% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 33 | 33 | $144,969 | $32,258 | 22.3% |
| J3590 | Unclassified biologics | Office | 2023 | 21 | 32 | $88,200 | $23,853 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $38,627 | $13,055 | 33.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 88 | 88 | $25,872 | $9,515 | 36.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 32 | 67 | $8,308 | $4,840 | 58.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 30 | 30 | $9,240 | $3,469 | 37.5% |
| 92250 | Photography of the retina | Office | 2023 | 55 | 56 | $9,912 | $1,689 | 17.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,266 | $1,428 | 33.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 11 | 13 | $4,056 | $519.28 | 12.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,320 | $487.13 | 36.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 274 | 2,910 | $6.0M | $2.1M | 34.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 368 | 1,607 | $975,253 | $164,152 | 16.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 16 | 542 | $387,530 | $121,206 | 31.3% |
About Dr. David Saperstein, MD
Dr. David Saperstein, MD is a Ophthalmology healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508946625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Saperstein, MD has received a total of $55,281 in payments from pharmaceutical and medical device companies, with $23,313 received in 2024. These payments were reported across 82 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($52,419).
As a Medicare-enrolled provider, Saperstein has provided services to 12,568 Medicare beneficiaries, totaling 59,277 services with total Medicare billing of $11.3M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Bellevue, WA
- Active Since 10/16/2006
- Last Updated 08/21/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1508946625
Products in Payments
- EYLEA (Biological) $30,321
- EYLEA HD (Biological) $13,032
- EYLEA AFLIBERCEPT INJECTION (Biological) $5,081
- Syfovre (Drug) $4,440
- EYP-1901 (Drug) $1,410
- EVA Ophthalmic Surgical System (Device) $158.90
- Constellation (Device) $144.63
- SUSVIMO (Drug) $103.22
- RTH258A (Drug) $51.47
- Izervay (Drug) $43.33
- Vabysmo (Drug) $37.53
- Susvimo (Drug) $34.84
- Lucentis (Biological) $34.65
- BEOVU (Drug) $32.31
- BOTOX THERAPEUTIC (Biological) $27.45
- VABYSMO (Drug) $21.44
- YUTIQ (Drug) $21.00
- XIPERE (Drug) $20.92
- Cimerli (Biological) $17.85
- Stellaris (Device) $15.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Bellevue
Dr. Audrey Rostov, Md, MD
Ophthalmology — Payments: $166,425
Ophthalmology $166,425
Howard Barnebey, M.d, M.D
Ophthalmology — Payments: $78,978
Ophthalmology $78,978
Kristin Tarbet, Md, MD
Ophthalmology — Payments: $34,759
Ophthalmology $34,759
Dr. Mary Coday, M.d, M.D
Ophthalmology — Payments: $9,706
Ophthalmology $9,706
Karan Patel, M.d, M.D
Ophthalmology — Payments: $5,865
Ophthalmology $5,865
Dr. Michael Gilbert, Md, MD
Ophthalmology — Payments: $5,318
Ophthalmology $5,318